{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:33:02Z","timestamp":1761550382871,"version":"build-2065373602"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T00:00:00Z","timestamp":1211500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["openrespiratorymedicinejournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TORMJ"],"published-print":{"date-parts":[[2008,5,23]]},"abstract":"<jats:p>\n                    Tuberculin skin testing (TST) and Interferon-gamma (IFN\u03b3)release assays (IGRAs) are presently the only available assays for the detection of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    infected individuals. IGRAs might progressively replace TST, as numerous published reports establish their higher specificity and similar sensitivity when tested in BCG vaccinated, immunocompetent individuals or in populations who may have been in contact with atypical mycobacteria. However, few published reports have commented on their role in TB diagnosis in immunocompromised individuals (HIV, immunosuppressive therapy, cancer\u2026). It is the purpose of this report to review IGRAs published studies in HIV individuals in endemic and non endemic area for tuberculosis (TB). IGRAs were tested in the presence or absence of active TB but correlated to duration of exposure. In newly diagnosed active TB, IGRAs demonstrated a similar sensitivity to TST. In TB non infected individuals, TST and IGRAs also gave similar values when categorization of individuals was correlated to the risk of infection. A higher number of positive IGRAs was observed in individuals from TB endemic areas, in similar proportions to immunocompetent individuals. Comparison between the two IGRAs: QuantiFERON-TB Gold\n                    <jats:sup>\u00ae<\/jats:sup>\n                    (QF-TB, Cellestis, Australia) and T-SPOT-TB\n                    <jats:sup>\u00ae<\/jats:sup>\n                    (Oxford Immunotec, UK), and against TST, in the same HIV population demonstrates a higher sensitivity of T-SPOT-TB and TST than QF-TB. Indeterminate results, which correspond to the absence of a positive T-cell IFN\u03b3 response towards phytohemaglutinin (PHA), is a key point when comparing both IGRAs. This PHA control is indicative of the level of immunosuppression observed in the tested individual. QF-TB seems to present, in HIV populations, more indeterminate results than T-SPOT-TB. The calibration and\/or concentration of PBMC on nitrocellulose membrane for the T-SPOT-TB, as compared to a whole blood assay, might explain this difference, with less indeterminate results with the T-SPOT-TB assay. Neither assay is able to differentiate active TB from latent TB infection (LTBI). Several laboratories have tried new antigenic epitopes to solve this issue. It is of importance that these studies need to be repeated on a larger scale by others to validate their results. Two blood assays might add information characterising the evolution from LTBI to active TB: either by losing protective immunity, as demonstrated by the whole blood killing assay, or by evaluating the kinetics of the antibodies synthesized against\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    specific antigens. In conclusion, longitudinal studies are still needed to validate IGRAs and other assays and to define their respective predictive values.\n                  <\/jats:p>","DOI":"10.2174\/1874306400802010052","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T13:18:45Z","timestamp":1212499125000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnosing Latent Tuberculosis Infection in the HIV Era"],"prefix":"10.2174","volume":"02","author":[{"given":"Philippe H","family":"Lagrange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Louis","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","volume":"347","author":"Jasmer RM","year":"2002","unstructured":"Jasmer RM, Nahid P, Hopewell PC. \n                Clinical practice. Latent Tuberculosis infection \n                N Engl J Med  \n                2002; \n                347\n                : 1860-6.","journal-title":"N Engl J Med"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(03)00741-2","volume":"3","author":"Tufariello JM","year":"2003","unstructured":"Tufariello JM, Chan J, Flynn JL. \n                Latent tuberculosis: mechanisms of the host and bacillus that contribute to persistent infection \n                Lancet Infect Dis  \n                2003; \n                3\n                : 578-90.","journal-title":"Lancet Infect Dis"},{"unstructured":"World Health Organisation. \n                Global Tuberculosis Control-Surveillance Planing Financing \n                WHO report 2005 Geneva Switzerland \n                2005.","key":"refR3"},{"key":"refR4","first-page":"1","volume":"20","author":"Styblo K","year":"1980","unstructured":"Styblo K. \n                Recent advances in epidemiological research in tuberculosis \n                Adv Tuberc Res  \n                1980; \n                20\n                : 1-63.","journal-title":"Adv Tuberc Res"},{"key":"refR5","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","year":"2000","unstructured":"American Thoracic Society. \n                Targeted tuberculin testing and treatment of latent tuberculosis infection \n                Am J Respir Crit Care Med  \n                2000; \n                161\n                : S221-247.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.283.22.2968","volume":"283","author":"Chin DP","year":"2000","unstructured":"Chin DP, Crane CM, Diul MY, et al. \n            Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control \n            JAMA  \n            2000; \n            283\n            : 2968-74.","journal-title":"JAMA"},{"key":"refR7","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1001\/jama.293.22.2785","volume":"293","author":"Whalen CC","year":"2004","unstructured":"Whalen CC. \n            Diagnosis of Latent Tuberculosis Infection \n            JAMA  \n            2004; \n            293\n            : 2785-7.","journal-title":"JAMA"},{"key":"refR8","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","volume":"350","author":"Horsburgh CR jr","year":"2004","unstructured":"Horsburgh CR jr. \n            Priorities for the treatment of latent tuberculosis infection in the United States \n            N Engl J Med  \n            2004; \n            350\n            : 2060-7.","journal-title":"N Engl J Med"},{"key":"refR9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","volume":"359","author":"Badri M","year":"2002","unstructured":"Badri M, Wilson D, Wood R. \n            Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study \n            Lancet  \n            2002; \n            359\n            : 2059-64.","journal-title":"Lancet"},{"key":"refR10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","volume":"19","author":"Lawn SD","year":"2005","unstructured":"Lawn SD, Bekker LG, Wood R. \n            How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control \n            AIDS  \n            2005; \n            19\n            : 1113-24.","journal-title":"AIDS"},{"key":"refR11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","volume":"172","author":"Seyler C","year":"2005","unstructured":"Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. \n            Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan \n            Am J Respir Crit Care Med  \n            2005; \n            172\n            : 123-7.","journal-title":"Am J Respir Crit Care Med"},{"unstructured":"Stop TB Partnership and WHO. The Global Plan to Stop TB 2006-2015 \n            Geneva: World Health Organistionhttp:\/\/www.stoptb.org\/globalplan\/plan_main.asp  \n            2006\n             [Jan 05, 2008];","key":"refR12"},{"key":"refR13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","volume":"17","author":"Huebner RE","year":"1993","unstructured":"Huebner RE, Schein MF, Bass JB Jr. \n            The Tuberculin Skin Test \n            Clin Infect Dis  \n            1993; \n            17\n            : 968-75.","journal-title":"Clin Infect Dis"},{"key":"refR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","volume":"99","author":"Comstock GW","year":"1974","unstructured":"Comstock GW, Livesay VT, Wollpert SF. \n            The prognosis of a positive tuberculin reaction in childhood and adolescence \n            Am J Epidemiol  \n            1974; \n            99\n            : 131-8.","journal-title":"Am J Epidemiol"},{"key":"refR15","first-page":"895","volume":"4","author":"Watkins RE","year":"2000","unstructured":"Watkins RE, Brennan R, Plant AJ. \n            Tuberculin reactivity and the risk of tuberculosis: a review \n            Int J Tuberc Lung Dis  \n            2000; \n            4\n            : 895-903.","journal-title":"Int J Tuberc Lung Dis"},{"key":"refR16","first-page":"1083","volume":"7","year":"2003","unstructured":"Tuberculosis Research Centre (ICMR), Chennai, India. \n            Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in South India: a 15 year follow up \n            Int J Tuberc Lung Dis  \n            2003; \n            7\n            : 1083-91.","journal-title":"Int J Tuberc Lung Dis"},{"key":"refR17","first-page":"28","volume":"26","author":"Ferebee SH","year":"1970","unstructured":"Ferebee SH. \n            Controlled chemoprophylaxis trials in tuberculosis. A general review \n             Bull Tuberc  \n            1970; \n            26\n            : 28-106.","journal-title":"Bull Tuberc"},{"key":"refR18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","volume":"337","author":"Whalen CC","year":"1997","unstructured":"Whalen CC, Johnson JL, Okwera A, et al. \n        A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration \n        N Engl J Med  \n        1997; \n        337\n        : 801-8.","journal-title":"N Engl J Med"},{"key":"refR19","first-page":"520","volume":"75","author":"Nuwaha F","year":"1998","unstructured":"Nuwaha F. \n        Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa \n        East Afr Med J  \n        1998; \n        75\n        : 520-7.","journal-title":"East Afr Med J"},{"key":"refR20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2105\/AJPH.88.5.792","volume":"88","author":"Malotte CK","year":"1998","unstructured":"Malotte CK, Rhodes F, Mais KE. \n        Tuberculosis screening and compliance with return for skin test reading among active drug users \n        Am J Public Health  \n        1998; \n        88\n        : 792-6.","journal-title":"Am J Public Health"},{"key":"refR21","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1164\/ajrccm.153.6.8665065","volume":"153","author":"Chin DP","year":"1996","unstructured":"Chin DP, Osmond D, Page-Shafer K, et al. \n    Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group \n     Am J Respir Crit Care Med  \n    1996; \n    153\n    : 1982-4.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR22","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/archinte.1995.00430190107015","volume":"155","author":"Caiaffa WT","year":"1995","unstructured":"Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D. \n        Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection \n        Arch Intern Med  \n        1995; \n        155\n        : 2111-7.","journal-title":"Arch Intern Med"},{"key":"refR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0035-9203(95)90649-5","volume":"89","author":"Duncan LE","year":"1995","unstructured":"Duncan LE, Elliott AM, Hayes RJ, et al. \n    Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study \n    Trans R Soc Trop Med Hyg  \n    1995; \n    89\n    : 37-40.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"refR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-119-3-199308010-00002","volume":"119","author":"Markowitz N","year":"1993","unstructured":"Markowitz N, Hansen NI, Wilcosky TC, et al. \n    Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group \n     Ann Intern Med  \n    1993; \n    119\n    : 185-93.","journal-title":"Ann Intern Med"},{"key":"refR25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"Pai M","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr. \n        Interferon-\u03b3 assays in the immunodiagnosis of tuberculosis: a systematic review \n        Lancet Inf Dis  \n        2004; \n        4\n        : 761-76.","journal-title":"Lancet Inf Dis"},{"key":"refR26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","author":"Andersen P","year":"2000","unstructured":"Andersen P, Munk ME, Pollock JM, Doherty TM. \n        Specific immune-based diagnosis of tuberculosis \n        Lancet  \n        2000; \n        356\n        : 1099-104.","journal-title":"Lancet"},{"key":"refR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcp.0000158726.13159.5e","volume":"11","author":"Dheda K","year":"2005","unstructured":"Dheda K, Udwadia ZF, Hugget JF, Johnson MA, Rook GA. \n            Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis \n            Curr Opin Pulm Med  \n            2005; \n            11\n            : 195-202.","journal-title":"Curr Opin Pulm Med"},{"key":"refR28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/14787210.3.6.981","volume":"3","author":"Rothel JS","year":"2005","unstructured":"Rothel JS, Andersen P. \n            Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? \n            Expert Rev Anti Infect Ther  \n            2005; \n            3\n            : 981-93.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"refR29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200509-1516PP","volume":"174","author":"Richeldi L","year":"2006","unstructured":"Richeldi L. \n            An update on the diagnosis of tuberculosis infection \n            Am J Respir Crit Care Med  \n            2006; \n            174\n            : 736-42.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0761-8425(07)91569-7","volume":"24","author":"Lagrange PH","year":"2007","unstructured":"Lagrange PH, Simonney N, Herrmann JL. \n            New immunological tests in the diagnosis of tuberculosis \n            Rev Mal Respir  \n            2007; \n            24\n            : 453-72.","journal-title":"Rev Mal Respir"},{"key":"refR31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"Menzies D","year":"2007","unstructured":"Menzies D, Pai M, Comstock G. \n            Meta-analysis: new tests for diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research \n            Ann Intern Med  \n            2007; \n            146\n            : 340-54.","journal-title":"Ann Intern Med"},{"key":"refR32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","volume":"28","author":"Lee JY","year":"2006","unstructured":"Lee JY, Choi HJ, Park IN, et al. \n        Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection \n        Eur Respir J  \n        2006; \n        28\n        : 24-30.","journal-title":"Eur Respir J"},{"key":"refR33","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"Kang YA","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI, et al. \n    Discrepancy between the tuberculin skin test and the whole-blood interferon-gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis burden country \n    JAMA  \n    2005; \n    293\n    : 2756-61.","journal-title":"JAMA"},{"key":"refR34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","volume":"6","author":"Pai M","year":"2006","unstructured":"Pai M, Kalantri S, Dheda K. \n        New tools and emerging techniques for the diagnosis of tuberculosis: part I. Latent tuberculosis \n        Expert Rev Mol Diagn  \n        2006; \n        6\n        : 413-22.","journal-title":"Expert Rev Mol Diagn"},{"key":"refR35","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200211220-00008","volume":"16","author":"Chapman ALN","year":"2002","unstructured":"Chapman ALN, Munkanta M, Wilkinson KA, et al. \n    Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis specific T cells \n    AIDS  \n    2002; \n    16\n    : 2285-93.","journal-title":"AIDS"},{"key":"refR36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2249.2007.03462.x","volume":"150","author":"Vincenti D","year":"2007","unstructured":"Vincenti D, Carrara S, Butera FO, et al. \n    Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study \n    Clin Exp Immunol  \n    2007; \n    150\n    : 91-8.","journal-title":"Clin Exp Immunol"},{"key":"refR37","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/518234","volume":"44","author":"Rangaka MX","year":"2007","unstructured":"Rangaka MX, Diwakar L, Seldon R, et al. \n    Clinical, immunological and epidemiological importance of antituberculous T cell responses in HIV-infected Africans \n    Clin Infect Dis  \n    2007; \n    44\n    : 1639-46.","journal-title":"Clin Infect Dis"},{"key":"refR38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2249.2007.03477.x","volume":"150","author":"Clark SA","year":"2007","unstructured":"Clark SA, Martin SL, Pozniak A, et al. \n    Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patient with advanced diseases \n    Clin Exp Immunol  \n    2007; \n    150\n    : 238-44.","journal-title":"Clin Exp Immunol"},{"key":"refR39","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-56","author":"Brock I","year":"2006","unstructured":"Brock I, Ruhwald M, Lundgren B, Westh H, Mathiensen LR, Ravn P. \n        Latent tuberculosis infection in HIV positive, diagnosed by the M. tuberculosis specific Interferon-\u03b3 test \n        Respir Res  \n        2006\n         [Published online 2006 April 1];","journal-title":"Respir Res"},{"key":"refR40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","volume":"175","author":"Luetkemeyer AF","year":"2007","unstructured":"Luetkemeyer AF, Charlebois ED, Flores LL, et al. \n    Comparison of an Interferon-\u03b3 release assay with tuberculin skin testing in HIV- infected individuals \n    Am J Respir Crit Care Med  \n    2007; \n    175\n    : 737-42.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR41","first-page":"1190","volume":"11","author":"Jones S","year":"2007","unstructured":"Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. \n        Utility of QuantiFERON-TB Gold in-tube testing for Latent TB infection in HIV-infected individuals \n        Int J Tuberc Lung Dis  \n        2007; \n        11\n        : 1190-5.","journal-title":"Int J Tuberc Lung Dis"},{"key":"refR42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","volume":"175","author":"Rangaka MX","year":"2007","unstructured":"Rangaka MX, Wilkinson KA, Seldon R, et al. \n    Effect of HIV-1 infection on T-cell-based and skin test detection in tuberculosis infection \n    Am J Respir Crit Care Med  \n    2007; \n    175\n    : 514-20.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1371\/journal.pone.0001441","volume":"3","author":"Karam F","year":"2008","unstructured":"Karam F, Mbow F, Fletcher H, et al. \n    Sensitivity of IFN-\u03b3 release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV\/AIDS progression \n    PLoS ONE  \n    2008; \n    3\n    (1)\n    : 1441.","journal-title":"PLoS ONE"},{"key":"refR44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2334-7-99","volume":"7","author":"Lawn SD","year":"2007","unstructured":"Lawn SD, Bangani N, Vogt MT, et al. \n        Utility of interferon-? ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa \n        BMC Infect Dis  \n        2007; \n        7\n        : 99.","journal-title":"BMC Infect Dis"},{"key":"refR45","first-page":"168","volume":"12","author":"Swaminathan S","year":"2008","unstructured":"Swaminathan S, Subbaraman R, Venkatesan P, et al. \n    Tuberculin skin tests results in HIV-infected patients in India: implications for latent tuberculosis treatment \n    Int J Tuberc Lung Dis  \n    2008; \n    12\n    : 168-73.","journal-title":"Int J Tuberc Lung Dis"},{"key":"refR46","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1097\/01.aids.0000191923.08938.5b","volume":"19","author":"Dheda K","year":"2005","unstructured":"Dheda K, Lalvani A, Miller RF, et al. \n    Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count \n    AIDS  \n    2005; \n    19\n    : 2038-41.","journal-title":"AIDS"},{"key":"refR47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijid.2007.02.001","volume":"11","author":"Siawaya JFD","year":"2007","unstructured":"Siawaya JFD, Ruhwald M, Eugen-Olsen J, Walzi G. \n        Correlates for disease progression and prognosis of concurrent HIV\/TB infection \n        Int J Infect Dis  \n        2007; \n        11\n        : 289-99.","journal-title":"Int J Infect Dis"},{"key":"refR48","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/523012","volume":"45","author":"Goletti D","year":"2007","unstructured":"Goletti D, Carrara S, Vincenti D, Girardi E. \n        T cell responses to commercial Mycobacterium tuberculosis-specific antigens in HIV-infected patients \n        Clin Infect Dis  \n        2007; \n        45\n        : 1652-4.","journal-title":"Clin Infect Dis"},{"key":"refR49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/JCM.40.2.704-706.2002","volume":"4","author":"Doherty TM","year":"2002","unstructured":"Doherty TM , Demissie A, Olobo J, et al. \n        Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal sub-clinical infection among contacts of tuberculosis patients \n        J Clin Microbiol  \n        2002; \n        4\n        : 704-6.","journal-title":"J Clin Microbiol"},{"key":"refR50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molmed.2007.03.004","volume":"13","author":"Andersen P","year":"2007","unstructured":"Andersen P , Doherty TM, Pai M, Weldingh K. \n            The prognosis of latent tuberculosis: can disease be predicted? \n            Trends Mol Med  \n            2007; \n            13\n            : 175-82.","journal-title":"Trends Mol Med"},{"key":"refR51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1469-0691.2006.01391.x","volume":"12","author":"Goletti D","year":"2006","unstructured":"Goletti D, Carrara S, Vincenti D, et al. \n            Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study \n            Clin Microbiol Infect  \n            2006; \n            12\n            : 544-50.","journal-title":"Clin Microbiol Infect"},{"key":"refR52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2334-8-11","volume":"8","author":"Goletti D","year":"2008","unstructured":"Goletti D, Carrara S, Mayanja-Kissa H, et al. \n        Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study \n        BMC Infect Dis  \n        2008; \n        8\n        : 11.","journal-title":"BMC Infect Dis"},{"key":"refR53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1371\/journal.pone.0000926","volume":"2","author":"Hougardy JM","year":"2007","unstructured":"Hougardy JM , Schepers K, Place S, et al. \n        Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis \n        PLos ONE  \n        2007; \n        2\n        (10)\n        : 926.","journal-title":"PLos ONE"},{"key":"refR54","first-page":"239","volume":"3","author":"Elliott AM","year":"1999","unstructured":"Elliott AM, Hurst TJ, Balyeku MN, et al. \n    The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study \n    Int J Tuberc Lung Di  \n    1999; \n    3\n    : 239-47.","journal-title":"Int J Tuberc Lung Di"},{"key":"refR55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/156652407780598520","volume":"7","author":"Fletcher HA","year":"2007","unstructured":"Fletcher HA. \n        Correlates of immune protection from tuberculosis \n        Cur Mol Med  \n        2007; \n        7\n        : 319-25.","journal-title":"Cur Mol Med"},{"key":"refR56","first-page":"544","volume":"187","author":"Tena GN","year":"2003","unstructured":"Tena GN , Young DB, Eley B, et al. \n            Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function \n            J Infect Dis  \n            2003; \n            187\n            : 544-1551.","journal-title":"J Infect Dis"},{"key":"refR57","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/01.aids.0000222073.45372.ce","volume":"20","author":"Kampmann B","year":"2006","unstructured":"Kampmann B, Tena-Coki GN, Nicol MP, Levin M, Eley B. \n                Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART \n                AIDS  \n                2006; \n                20\n                : 1011-8.","journal-title":"AIDS"},{"key":"refR58","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","volume":"359","author":"Badri M","year":"2002","unstructured":"Badri M, Wilson D, Wood R. \n                Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study \n                Lancet  \n                2002; \n                359\n                : 2059-64.","journal-title":"Lancet"},{"key":"refR59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-3083.2007.01978.x","volume":"66","author":"Abebe F","year":"2007","unstructured":"Abebe F, Holm-Hansent C, Wiker HG, Bjune G. \n                Progress in serodiagnosis of Mycobacterium infection \n                Scand J Immunol  \n                2007; \n                66\n                : 176-91.","journal-title":"Scand J Immunol"},{"key":"refR60","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/infdis\/168.6.1409","volume":"168","author":"Saltini C","year":"1993","unstructured":"Saltini C, Amicosante M, Girardi E, et al. \n                Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection \n                J Infect Dis  \n                1993; \n                168\n                : 1409-14.","journal-title":"J Infect Dis"},{"key":"refR61","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/518656","volume":"196","author":"Perkins MD","year":"2007","unstructured":"Perkins MD, Cunnigham J. \n                        Facing the crisis: improving the diagnosis of tuberculosis in the HIV era \n                        J Infect Dis  \n                        2007; \n                        196\n                        (Suppl 1)\n                         : S15-27.","journal-title":"J Infect Dis"},{"key":"refR62","first-page":"911","volume":"62","author":"Steingart KR","year":"2007","unstructured":"Steingart KR, Henry M, Laal S, et al. \n                    A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis \n                    Thorax  \n                    2007; \n                    62\n                    : 911-8.","journal-title":"Thorax"},{"key":"refR63","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1016\/j.tube.2006.05.005","volume":"87","author":"Simonney N","year":"2007","unstructured":"Simonney N, Chavanet P, Perronne C, et al. \n                            B-cell immune responses in HIV positive and HIV negative patients with tuberculosis evaluated with an ELISA using a glycolipid antigen \n                            Tuberculosis  \n                            2007; \n                            87\n                            : 09-122.","journal-title":"Tuberculosis"},{"key":"refR64","first-page":"435","volume":"1","author":"Amicosante M","year":"1997","unstructured":"Amicosante M, Richeldi L, Monno L, et al. \n                            Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients \n                            Int J Tuberc Lung Dis  \n                            1997; \n                            1\n                            : 435-40.","journal-title":"Int J Tuberc Lung Dis"},{"key":"refR65","first-page":"354","volume":"12","author":"Singh KK","year":"2005","unstructured":"Singh KK, Dong Y, Belisle JT, Harder J, Arora VK, Laal S. \n                            Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, sub-clinical tuberculosis \n                            Clin Diagn Lab Immunol  \n                            2005; \n                            12\n                            : 354-8.","journal-title":"Clin Diagn Lab Immunol"},{"key":"refR66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/510080","volume":"44","author":"Elzi L","year":"2007","unstructured":"Elzi L, Schlegel M, Weber R, et al. \n                        Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission \n                        Clin Infect Dis  \n                        2007; \n                        44\n                        : 94-102.","journal-title":"Clin Infect Dis"}],"container-title":["The Open Respiratory Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V02\/TORMJ-2-52\/TORMJ-2-52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V02\/TORMJ-2-52\/TORMJ-2-52.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrespiratorymedicinejournal.com\/contents\/volumes\/V02\/TORMJ-2-52\/TORMJ-2-52.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:27:50Z","timestamp":1761550070000},"score":1,"resource":{"primary":{"URL":"https:\/\/openrespiratorymedicinejournal.com\/VOLUME\/02\/PAGE\/52\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,23]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5,23]]}},"alternative-id":["TORMJ-2-52"],"URL":"https:\/\/doi.org\/10.2174\/1874306400802010052","relation":{},"ISSN":["1874-3064"],"issn-type":[{"type":"print","value":"1874-3064"}],"subject":[],"published":{"date-parts":[[2008,5,23]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2008-3-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-5-2","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-5-7","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}